Terms: = Endocrine gland cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
39 results:
1. Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer.
Zang L; Zhang B; Zhou Y; Zhang F; Tian X; Tian Z; Chen D; Miao Q
Aging (Albany NY); 2023 Dec; 15(23):14109-14140. PubMed ID: 38095640
[TBL] [Abstract] [Full Text] [Related]
2. All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer.
Jorgensen K; Denham C; Kanbergs A; Wu CF; Nitecki R; Agusti N; Meernik C; Melamed A; Rauh-Hain JA
Gynecol Oncol; 2023 Nov; 178():60-68. PubMed ID: 37801736
[TBL] [Abstract] [Full Text] [Related]
3. BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic cancer treatment.
Li M; Duan X; Xiao Y; Yuan M; Zhao Z; Cui X; Wu D; Shi J
Front Public Health; 2022; 10():900853. PubMed ID: 35769782
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
[TBL] [Abstract] [Full Text] [Related]
5. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma.
Wu R; Liu W; Li N; Wang X; Sun D; Ji Y; Jia Q; Tan J; Zheng W
Nucl Med Commun; 2022 Jun; 43(6):669-674. PubMed ID: 35351838
[TBL] [Abstract] [Full Text] [Related]
7. Could Urinary Iodine Be an Effective Predictive Factor for Thyroid cancer After High Dose Radioactive Iodine Therapy?
Cao J; Yun C; Zhu X; Sun Y; Li X; Zhang W
Endocr Pract; 2022 Jun; 28(6):586-592. PubMed ID: 35304327
[TBL] [Abstract] [Full Text] [Related]
8. Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
Ullgren H; Fransson P; Olofsson A; Segersvärd R; Sharp L
PLoS One; 2021; 16(7):e0254673. PubMed ID: 34270589
[TBL] [Abstract] [Full Text] [Related]
9. Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
Lee CK; Friedlander ML; Tjokrowidjaja A; Ledermann JA; Coleman RL; Mirza MR; Matulonis UA; Pujade-Lauraine E; Bloomfield R; Goble S; Wang P; Glasspool RM; Scott CL;
Cancer; 2021 Jul; 127(14):2432-2441. PubMed ID: 33740262
[TBL] [Abstract] [Full Text] [Related]
10. Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer.
Merlo S; Besic N; Drmota E; Kovacevic N
Radiol Oncol; 2021 Aug; 55(3):341-346. PubMed ID: 33675192
[TBL] [Abstract] [Full Text] [Related]
11. The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study.
Strøm Kahr H; Christiansen OB; Juul Riddersholm S; Gade IL; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
J Thromb Haemost; 2021 Apr; 19(4):992-1000. PubMed ID: 33420762
[TBL] [Abstract] [Full Text] [Related]
12. An iodine-125 seed strand combined with a metal stent versus a metal stent alone for obstructive jaundice caused by pancreatic ductal adenocarcinoma.
Li J; Yu T; Zhang L; Yang M; Gao S; Pu N; Li C; Wang C; Gong G; Cheng J; Wang L; Li G; Wang X; Chen Y
Brachytherapy; 2021; 20(2):446-453. PubMed ID: 33309002
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear Atypia Is a Necessary Factor for Diagnosis of Primary Ovarian Fibrosarcoma: A Case Report and Literature Review.
Zhang Z; Yao A; Xin Q; Shi Y; Zhang A
Gynecol Obstet Invest; 2020; 85(5):437-445. PubMed ID: 33011729
[TBL] [Abstract] [Full Text] [Related]
14. Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study.
Adelborg K; Farkas DK; Sundbøll J; Schapira L; Tamang S; Cullen MR; Cronin-Fenton D; Sørensen HT
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32611556
[TBL] [Abstract] [Full Text] [Related]
15. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
Konstantinopoulos PA; Cheng SC; Wahner Hendrickson AE; Penson RT; Schumer ST; Doyle LA; Lee EK; Kohn EC; Duska LR; Crispens MA; Olawaiye AB; Winer IS; Barroilhet LM; Fu S; McHale MT; Schilder RJ; Färkkilä A; Chowdhury D; Curtis J; Quinn RS; Bowes B; D'Andrea AD; Shapiro GI; Matulonis UA
Lancet Oncol; 2020 Jul; 21(7):957-968. PubMed ID: 32553118
[TBL] [Abstract] [Full Text] [Related]
16. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
[TBL] [Abstract] [Full Text] [Related]
17. Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery.
Castro BGR; Dos Reis R; Cintra GF; Sousa MMA; Vieira MA; Andrade CEMDC
Int J Gynecol Cancer; 2018 Oct; 28(8):1520-1528. PubMed ID: 30036229
[TBL] [Abstract] [Full Text] [Related]
18. Enhancing the Potency and Specificity of Engineered T Cells for cancer treatment.
Sukumaran S; Watanabe N; Bajgain P; Raja K; Mohammed S; Fisher WE; Brenner MK; Leen AM; Vera JF
Cancer Discov; 2018 Aug; 8(8):972-987. PubMed ID: 29880586
[TBL] [Abstract] [Full Text] [Related]
19. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic cancer Patients? A National Study.
de Geus SWL; Kasumova GG; Eskander MF; Ng SC; Kent TS; James Moser A; Vahrmeijer AL; Callery MP; Tseng JF
J Gastrointest Surg; 2018 Feb; 22(2):214-225. PubMed ID: 29235000
[TBL] [Abstract] [Full Text] [Related]
20. Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
Wang C; Zhang X; Li H; Li X; Lin Y
PLoS One; 2017; 12(7):e0179664. PubMed ID: 28704384
[TBL] [Abstract] [Full Text] [Related]
[Next]
